Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions
Prostate Cancer
Interventions
DRUG

[18F]PSMA-1007

Diagnostic radiopharmaceutical for PET scan

Trial Locations (17)

Unknown

RECRUITING

CHRU de Nancy, Nancy

NOT_YET_RECRUITING

Carl Gustav Carus Faculty of Medicine, TUD Dresden, Dresden

RECRUITING

University Hospital Düsseldorf, Düsseldorf

RECRUITING

St. Antonius Hospital, Gronau

RECRUITING

University Hospital Hamburg-Eppendorf, Hamburg

RECRUITING

University Hospital Leipzig, Leipzig

RECRUITING

Klinikum rechts der Isar, TUM, München

RECRUITING

University Hospital Münster, Münster

NOT_YET_RECRUITING

Universitätsmedizin Rostock, Rostock

NOT_YET_RECRUITING

IRCCS, Meldola

RECRUITING

The University of Osaka Hospital, Osaka

RECRUITING

National Cancer Center, Tokyo

NOT_YET_RECRUITING

CWZ, Nijmegen

NOT_YET_RECRUITING

Radboud UMC, Nijmegen

RECRUITING

Hospital Del Mar, Barcelona

RECRUITING

Hospital Vall d'Hebron, Barcelona

RECRUITING

Hospital Vithas Valencia 9 de Octubre, Valencia

All Listed Sponsors
lead

ABX advanced biochemical compounds GmbH

INDUSTRY